IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease
City AM
—
IMU has built the world’s largest immune dataset and can use a simple blood sample to measure over 100 million immune data points, providing precise actionable insights for patients and healthcare providers Proceeds from the latest round will support IMU’s operational expansion and development of clinical platform and infrastructure, alongside advancing the Company’s clinical programmes